Table 4.
Cox Models for All-Cause Mortality in Patients With Nonobstructive CAD
| Models | Hazard Ratio* (95% CI) | P Value |
|---|---|---|
| All patients (n=10 418) | ||
| Statin therapy | 0.52 (0.34–0.79) | 0.002 |
| ASA therapy | 0.77 (0.53–1.12) | 0.173 |
| Nonobstructive CAD (n=4706) | ||
| Statin therapy | 0.39 (0.23–0.65) | <0.001 |
| ASA therapy | 0.66 (0.42–1.04) | 0.070 |
| No coronary plaque (n=5712) | ||
| Statin therapy | 0.64 (0.30–1.37) | 0.252 |
| ASA therapy | 0.73 (0.37–1.47) | 0.384 |
CAD indicates coronary artery disease; and CI, confidence interval.
*
Adjusted for National Cholesterol Education Program/Adult Treatment Program III risk.